Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience-Reference-Cited by-同舟云学术

Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience

Published:2018-05-24 Issue:1 Volume:48 Page:44-54
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Chen V. L.¹²^ORCID,Yeh M.-L.³,Le A. K.⁴,Jun M.⁵,Saeed W. K.⁶,Yang J. D.⁷,Huang C.-F.³^ORCID,Lee H. Y.⁶,Tsai P.-C.³,Lee M.-H.⁸,Giama N.⁷,Kim N. G.⁹,Nguyen P. P.⁴,Dang H.⁴,Ali H. A.⁷,Zhang N.⁷,Huang J.-F.³,Dai C.-Y.³,Chuang W.-L.³,Roberts L. R.⁷,Jun D. W.⁶^ORCID,Lim Y.-S.⁵,Yu M.-L.³^ORCID,Nguyen M. H.⁴^ORCID

Affiliation:

1. Division of Gastroenterology; University of Michigan Health System; Ann Arbor MI USA

2. Department of Medicine; Stanford University Medical Center; Stanford CA USA

3. Hepatobiliary Division; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan

4. Division of Gastroenterology and Hepatology; Stanford University Medical Center; Stanford CA USA

5. Department of Gastroenterology; Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea

6. Division of Gastroenterology; Hanyang University Medical Center; Seoul Korea

7. Department of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN USA

8. Institute of Clinical Medicine; National Yang-Ming University; Taipei Taiwan

9. Stanford University School of Medicine; Stanford CA USA

Funder

Ministry of Science and Technology, Taiwan